Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
중국 우한에서 항 SARS-CoV-2 항체의 혈청유병률 및 체액성 면역 내구성: 종단적, 인구 수준, 횡단면 연구
Observational Study
[키워드] 95% CI
Abstract
Academy
adjusted
analyses
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibody
Asymptomatic
asymptomatic individual
Asymptomatic individuals
baseline
blood sample
Blood samples
China
Chinese
Cluster
college
Community
confirmed case
confirmed cases
COVID-19 outbreak
cross-sectional
cross-sectional study
decrease
determine
diagnosis of COVID-19
eligible participant
Epicentre
family members
Follow-up
Follow-up visit
foundation
health-care
household
Households
humoral
Humoral response
humoral responses
IgA
IgA antibodies
IgG
IgG antibodies
IgG antibody
IgM
IgM antibodies
immune
immunoglobulins
immunological
Immunological testing
individual
Kinetics
mass vaccination
material
median
Medical Science
Medical Sciences
natural
Neutralising Antibodies
neutralising antibody
neutralising antibody titre
neutralising antibody titres
nucleocapsid protein
participant
population level
positive
Prevent
previous diagnosis
proportion
Protein
question
questionnaire
random
Randomly
remained
resurgence
SARS-CoV-2
SARS-CoV-2 nucleocapsid
Science
selected
seroconverting
Seroprevalence
significantly
study period
Symptom
symptomatic individuals
technology
tested
the epidemic
titre
titres
translation
union
vaccination
Vaccination strategies
venous
venous blood
were assessed
with COVID-19
Wuhan
[DOI] 10.1016/S0140-6736(21)00238-5 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/S0140-6736(21)00238-5 PMC 바로가기 [Article Type] Observational Study